Several studies indicate that SRC can affect major oncogenic pathways (e.g., the integrins, RTKs, WNT/β-catenin, Yes associated protein (YAP)/tafazzin (TAZ) and JAK/STAT signalling cascades) by direct or indirect mechanisms, and this may partly explain its tumour function [13,24,34,35]. Here, SRC is linked to neoplasm.